益肾活血通络饮治疗糖尿病肾病的临床研究

朱泽林

doi:10.13898/j.cnki.issn.1000-2200.2018.02.017

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

益肾活血通络饮治疗糖尿病肾病的临床研究

朱泽林

文章导航 > 蚌埠医学院学报 > 2018, 43 > 2: (198-200,205)

引用本文:

Citation:

益肾活血通络饮治疗糖尿病肾病的临床研究

朱泽林

湖北省阳新县人民医院肾病内科, 435200

作者简介: 朱泽林(1970-),男,主治医师.

中图分类号: R587.2;R692.9

Effect of Yishen Huoxue Tongluo Yin in the treatment of diabetic nephropathy

ZHU Ze-lin

Department of Kidney Disease, The People's Hospital of Yangxin, Yangxin Hubei 435200, China
CLC number: R587.2;R692.9

摘要: 目的：探讨益肾活血通络饮治疗糖尿病肾病的临床效果。方法：选取糖尿病肾病病人84例，随机分为对照组和观察组，各42例。对照组予缬沙坦胶囊治疗，观察组予益肾活血通络饮治疗，比较2组临床疗效和相关指标。结果：观察组总有效率为88.09%，高于对照组的73.81%（P<0.05）。2组病人治疗前尿微量白蛋白、24 h尿微量白蛋白、尿素氮、血清肌酐和肾小球滤过率差异均无统计学意义（P>0.05），治疗后观察组各指标均较治疗前明显改善（P<0.01），且治疗后观察组各指标均明显优于对照组（P<0.01）。2组治疗前单核细胞趋化因子（MCP-1）、血清超敏C反应蛋白（hs-CRP）和肿瘤坏死因子-α（TNF-α）差异均无统计学意义（P>0.05）；治疗后观察组MCP-1、hs-CRP、TNF-α均较治疗前明显下降（P<0.01），而对照组治疗前后MCP-1、hs-CRP、TNF-α差异均无统计学意义（P>0.05），且治疗后观察组MCP-1、hs-CRP和TNF-α均低于对照组（P<0.05~P<0.01）。结论：益肾活血通络饮治疗糖尿病肾病具有较好效果。
- 糖尿病肾病 /
- 益肾活血通络饮 /
- 缬沙坦
Abstract: Objective: To investigate the clinical effects of Effect of Yishen Huoxue Tongluo Yin in the treatment of diabetic nephropathy.Methods: Eighty-four patients with diabetic nephropathy were randomly divided into the control group and observation group(42 cases each group).The control group and observation group were treated with valsartan capsule and Yishen Huoxue Tongluo Yin,respectively.The clinical effects and related indexes between two groups were compared.Results: The total effective rate in observation group(88.09%) was higher than that in control group(73.81%)(P<0.05).Before treatment,the differences of the levels of urinary albumin,24 h urinary albumin,urea nitrogen,serum creatinine and glomerular filtration rate between two groups were not statistically significant(P>0.05).After treatment,all indexes in observation group were significantly improved(P<0.01),and which in observation group was significantly better than that in control group(P<0.01).Before treatment,the differences of the levels of MCP-1,hs-CRP and TNF-α between two groups were not statistically significant(P>0.05).After treatment,the levels of MCP-1,hs-CRP and TNF-α in observation group significantly decreased compared with before treatment(P<0.01),the differences of the levels of MCP-1,hs-CRP and TNF-α in control group between before and after treatment were not statistically significant(P>0.05),and the levels of MCP-1,hs-CRP and TNF-α in observation group were lower than those in control group(P<0.05 to P<0.01).Conclusions: The treatment effect of diabetic nephropathy with Yishen Huoxue Tongluo Yin is good.
- diabetic nephropathy /
- Yishen Huoxue Tongluo Yin /
- valsartan

[1]	毕菲菲,姚岚,王敏,等.益气养阴活血通络方治疗糖尿病肾病疗效观察[J].陕西中医,2015,3(3):304.
[2]	胡宝峰,黄明,李秋英,等.降糖益肾片治疗糖尿病肾病42例临床研究[J].辽宁中医学院学报,2011,3(1):6.
[3]	罗静,沈慧平,王韶军,等.益气养阴活血通络方对糖尿病肾病大鼠肾脏的作用研究[J].中国中西医结合肾病杂志,2012,13(8):707.
[4]	罗静,王韶军,王利军,等.益气养阴、活血通络法治疗糖尿病肾病40例临床研究[J].江苏中医药,2012,44(7):22.
[5]	李洁,杨洪涛,杨波,等.益气养阴、活血通络法对糖尿病肾病(Ⅲ期)中医证候及尿蛋白影响的研究[J].中国中西医结合肾病杂志,2013,14(3):230.
[6]	冯春俭.益气活血通络法治疗糖尿病肾病Ⅲ~Ⅳ期的临床观察[J].吉林医学,2014,35(9):1813.
[7]	刘必利,吴冰.保肾汤治疗糖尿病肾病46例疗效观察[J].四川中医,2014,22(12):54.
[8]	梁惠.益气养阴活血通络法对糖尿病肾病治疗作用的临床观察[J].中国保健营养(中旬刊),2013,3(5):683.
[9]	张玉萍.中西药联合治疗糖尿病肾病70例疗效观察[J].中国保健营养(上旬刊),2013,7(10):6024.):6024.
[10]	柴可夫,沈祥峰.通络法在糖尿病肾病治疗中的运用[J].中华中医药学刊,2011,25(8):1553.

[1]	王晓红 . 肾炎康复片联合缬沙坦治疗糖尿病肾病临床疗效评价. 蚌埠医学院学报, 2014, 38(1): 81-83.
[2]	胡延毅 , 龙红英 , 王鲸竹 . 不同剂量坎地沙坦治疗糖尿病肾病合并高血压效果评价. 蚌埠医学院学报, 2015, 40(1): 62-64. doi: 10.13898/j.cnki.issn.1000-2200.2015.01.020
[3]	黄殿红 , 李廷振 . 坎地沙坦酯治疗早期糖尿病肾病32例. 蚌埠医学院学报, 2014, 39(11): 1553-1555.
[4]	刘浩 . 前列地尔联合替米沙坦治疗糖尿病肾病疗效观察. 蚌埠医学院学报, 2016, 41(7): 861-862,865. doi: 10.13898/j.cnki.issn.1000-2200.2016.07.006
[5]	梁德平 . 阿托伐他汀对糖尿病肾病患者血脂及肾血流参数的影响. 蚌埠医学院学报, 2015, 39(7): 866-868. doi: 10.13898/j.cnki.issn.1000-2200.2015.07.009
[6]	于浩天 , 李杨 . 海昆肾喜对糖尿病肾病大鼠肾保护及对肾单核细胞趋化蛋白-1及其mRNA表达的影响. 蚌埠医学院学报, 2011, 36(2): 112-116.
[7]	王静 , 郝丽 , 陈卫东 . 普罗布考对糖尿病肾病大鼠肾组织转化生长因子-1及血红素加氧酶-1表达的影响. 蚌埠医学院学报, 2013, 37(10): 1229-1234.
[8]	霍强 , 杨敏 , 吴华璞 , 蒋志文 . 缬沙坦分散片人体生物等效性研究. 蚌埠医学院学报, 2008, 33(3): 347-349.
[9]	朱卫红 , 邓晓敏 , 冯文成 , 管阳太 . 苯磺酸氨氯地平和缬沙坦治疗清晨高血压的疗效观察. 蚌埠医学院学报, 2014, 38(6): 762-764.
[10]	徐萍芳 , 宋丽娟 , 姜衡 . 缬沙坦联合叶酸在社区老年H型高血压患者中的疗效观察. 蚌埠医学院学报, 2015, 40(6): 727-729. doi: 10.13898/j.cnki.issn.1000-2200.2015.06.009
[11]	朱雁洲 , 施展 , 叶椿香 . 缬沙坦氨氯地平复合制剂改善高血压患者血管弹性及颈动脉内膜中层厚度的作用. 蚌埠医学院学报, 2013, 37(12): 1584-1587.
[12]	李梅 . 血清胱抑素C及相关指标联合检测对糖尿病早期肾损害的临床价值. 蚌埠医学院学报, 2014, 39(8): 1104-1106.
[13]	周子琪 , 柳园 , 蔡倩 , 曾小庆 , 付平 , 胡雯 . 糖尿病肾病及慢性肾病合并糖尿病病人的膳食调查分析. 蚌埠医学院学报, 2021, 46(1): 107-110. doi: 10.13898/j.cnki.issn.1000-2200.2021.01.028
[14]	黄滢芝 , 汤步阳 , 常琳 , 郭法平 . 平均血小板体积变化与2型糖尿病和糖尿病肾病的关系. 蚌埠医学院学报, 2014, 38(1): 58-60.
[15]	李晓丽 , 孙卫华 , 裴晓艳 , 张士荣 , 周静 . 2型糖尿病肾病的危险因素分析. 蚌埠医学院学报, 2014, 39(12): 1621-1623.
[16]	汪吉平 . 糖尿病肾病血液透析患者动静脉内瘘的护理. 蚌埠医学院学报, 2006, 31(4): 428-430.
[17]	马圣宇 , 魏苏 . 阿托伐它汀治疗糖尿病肾病35例分析. 蚌埠医学院学报, 2009, 34(5): 409-410.
[18]	范静静 , 张晓梅 . 血浆内脂素、一氧化氮与2型糖尿病及糖尿病肾病的关系研究. 蚌埠医学院学报, 2012, 36(3): 267-270.
[19]	陆明 , 陈卫东 . 高同型半胱氨酸血症与糖尿病肾病相关性研究进展. 蚌埠医学院学报, 2009, 34(3): 272-275.
[20]	闫永红 , 张超 , 徐俊蛟 , 杨晓秋 . 阿托伐他汀对糖尿病肾病患者炎症状态的影响. 蚌埠医学院学报, 2010, 35(10): 1018-1020.

点击查看大图

计量

文章访问数: 3362
HTML全文浏览量: 453
PDF下载量: 49
被引次数: 0

益肾活血通络饮治疗糖尿病肾病的临床研究

朱泽林

作者简介: 朱泽林(1970-),男,主治医师.

湖北省阳新县人民医院肾病内科, 435200

收稿日期: 2016-03-31
录用日期: 2018-01-05

关键词:

摘要: 目的：探讨益肾活血通络饮治疗糖尿病肾病的临床效果。方法：选取糖尿病肾病病人84例，随机分为对照组和观察组，各42例。对照组予缬沙坦胶囊治疗，观察组予益肾活血通络饮治疗，比较2组临床疗效和相关指标。结果：观察组总有效率为88.09%，高于对照组的73.81%（P<0.05）。2组病人治疗前尿微量白蛋白、24 h尿微量白蛋白、尿素氮、血清肌酐和肾小球滤过率差异均无统计学意义（P>0.05），治疗后观察组各指标均较治疗前明显改善（P<0.01），且治疗后观察组各指标均明显优于对照组（P<0.01）。2组治疗前单核细胞趋化因子（MCP-1）、血清超敏C反应蛋白（hs-CRP）和肿瘤坏死因子-α（TNF-α）差异均无统计学意义（P>0.05）；治疗后观察组MCP-1、hs-CRP、TNF-α均较治疗前明显下降（P<0.01），而对照组治疗前后MCP-1、hs-CRP、TNF-α差异均无统计学意义（P>0.05），且治疗后观察组MCP-1、hs-CRP和TNF-α均低于对照组（P<0.05~P<0.01）。结论：益肾活血通络饮治疗糖尿病肾病具有较好效果。

English Abstract

Effect of Yishen Huoxue Tongluo Yin in the treatment of diabetic nephropathy

ZHU Ze-lin

Department of Kidney Disease, The People's Hospital of Yangxin, Yangxin Hubei 435200, China

Received Date: 2016-03-31
Accepted Date: 2018-01-05

Abstract: Objective: To investigate the clinical effects of Effect of Yishen Huoxue Tongluo Yin in the treatment of diabetic nephropathy.Methods: Eighty-four patients with diabetic nephropathy were randomly divided into the control group and observation group(42 cases each group).The control group and observation group were treated with valsartan capsule and Yishen Huoxue Tongluo Yin,respectively.The clinical effects and related indexes between two groups were compared.Results: The total effective rate in observation group(88.09%) was higher than that in control group(73.81%)(P<0.05).Before treatment,the differences of the levels of urinary albumin,24 h urinary albumin,urea nitrogen,serum creatinine and glomerular filtration rate between two groups were not statistically significant(P>0.05).After treatment,all indexes in observation group were significantly improved(P<0.01),and which in observation group was significantly better than that in control group(P<0.01).Before treatment,the differences of the levels of MCP-1,hs-CRP and TNF-α between two groups were not statistically significant(P>0.05).After treatment,the levels of MCP-1,hs-CRP and TNF-α in observation group significantly decreased compared with before treatment(P<0.01),the differences of the levels of MCP-1,hs-CRP and TNF-α in control group between before and after treatment were not statistically significant(P>0.05),and the levels of MCP-1,hs-CRP and TNF-α in observation group were lower than those in control group(P<0.05 to P<0.01).Conclusions: The treatment effect of diabetic nephropathy with Yishen Huoxue Tongluo Yin is good.